{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:57:20Z","timestamp":1767826640291,"version":"3.49.0"},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2017,8,28]],"date-time":"2017-08-28T00:00:00Z","timestamp":1503878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1111\/jcpt.12617","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T15:05:02Z","timestamp":1504019102000},"page":"170-180","source":"Crossref","is-referenced-by-count":19,"title":["Practical characteristics of adaptive design in phase 2 and 3 clinical trials"],"prefix":"10.1155","volume":"43","author":[{"given":"A.","family":"Sato","sequence":"first","affiliation":[{"name":"Graduate School of Comprehensive Human Sciences University of Tsukuba  Tsukuba Japan"},{"name":"Novartis Pharma K.K.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Shimura","sequence":"additional","affiliation":[{"name":"Graduate School of Comprehensive Human Sciences University of Tsukuba  Tsukuba Japan"},{"name":"Data Science Department Taiho Pharmaceutical Co. Ltd.  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-9163","authenticated-orcid":false,"given":"M.","family":"Gosho","sequence":"additional","affiliation":[{"name":"Department of Clinical Trial and Clinical Epidemiology Faculty of Medicine University of Tsukuba  Tsukuba Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,28]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.090506.155819"},{"key":"e_1_2_7_3_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration.Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. March 2004.https:\/\/www.fda.gov\/scienceresearch\/specialtopics\/criticalpathinitiative\/criticalpathopportunitiesreports\/ucm077262.htm. Accessed 25 March 2017."},{"key":"e_1_2_7_4_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration.Guidance for Industry. Adaptive Design Clinical Trials for Drugs and Biologics. Draft Guidance. February 2010.https:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/UCM201790.pdf. Accessed 25 March 2017."},{"key":"e_1_2_7_5_1","volume-title":"Adaptive Design Methods in Clinical Trials","author":"Chow SC","year":"2012"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-11"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1927"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2011.165"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-092012-112310"},{"key":"e_1_2_7_10_1","unstructured":"European Medicines Agency.Committee for medicinal products for human use (CHMP) reflection paper on methodological issues in confirmatory clinical trials planned with an adaptive design. October 2007.http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003616.pdf. Accessed 25 March 2017."},{"key":"e_1_2_7_11_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration.Adaptive Designs for Medical Device Clinical Studies Guidance for Industry and Food and Drug Administration Staff. July 2016.https:\/\/www.fda.gov\/downloads\/medicaldevices\/deviceregulationandguidance\/guidancedocuments\/ucm446729.pdf. Accessed 25 March 2017."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774510361542"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/2168479014522468"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-15-383"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6472"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-79"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774512461859"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/009286150904300503"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-13-145"},{"key":"e_1_2_7_20_1","first-page":"8","article-title":"Innovative approaches to clinical development and trial design","volume":"47","author":"Orloff JJ","year":"2011","journal-title":"Ann Ist Super Sanita"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.113.002769"},{"key":"e_1_2_7_22_1","first-page":"49","article-title":"Adaptive clinical trial designs in oncology","volume":"3","author":"Zang Y","year":"2014","journal-title":"Chin Clin Oncol"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141104"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1273-9"},{"key":"e_1_2_7_25_1","unstructured":"World Health Organization.International Classification of Diseases (ICD) http:\/\/www.who.int\/classifications\/icd\/en\/. Accessed 25 March 2017."},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4312"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12328"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-608117"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413500727"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2013.12.007"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202221"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12305"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S55682"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/aja.2012.51"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70102-9"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533441"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.00853.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.734"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.1999.01286.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2001.00886.x"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.2307\/2533262"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19990730)18:14<1833::AID-SIM221>3.0.CO;2-3"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.200710453"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3048"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2389"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3436"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.3424"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2005.02.009"},{"key":"e_1_2_7_49_1","unstructured":"BarsanWG BerryDA LewisRJ.Accelerating Drug and Device Evaluation through Innovative Clinical Trial Design.http:\/\/grantome.com\/grant\/NIH\/U01-NS073476-01. Accessed 25 March 2017."},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/1740774509104992"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.004288"},{"key":"e_1_2_7_52_1","article-title":"Trends in study design and the statistical methods employed in a leading general medicine journal","author":"Gosho M","year":"2017","journal-title":"J Clin Pharm Ther"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12617","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.12617","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jcpt.12617","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jcpt.12617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:03:17Z","timestamp":1671818597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,28]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/jcpt.12617"],"URL":"https:\/\/doi.org\/10.1111\/jcpt.12617","archive":["Portico"],"relation":{},"ISSN":["0269-4727","1365-2710"],"issn-type":[{"value":"0269-4727","type":"print"},{"value":"1365-2710","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,28]]}}}